The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2026

Filed:

Nov. 11, 2022
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Zhiliang Cheng, Newtown, PA (US);

Andrew Tsourkas, Bryn Mawr, PA (US);

Ling Qin, Moorestown, PA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/44 (2006.01); A61K 9/1273 (2025.01); A61P 9/02 (2006.01); A61P 19/02 (2006.01); A61P 39/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/446 (2013.01); A61K 9/1273 (2013.01); A61P 9/02 (2018.01); A61P 19/02 (2018.01); A61P 39/06 (2018.01);
Abstract

Therapeutic compositions, comprising: an anti-reactive oxygen species agent and a pervious polymersome, the pervious polymersome encapsulating the anti-reactive oxygen species agent, and the pervious polymersome having therein channels defined by a channel diblock copolymer, the channels being arranged so as to retain at least some of the anti-reactive oxygen species agent within the pervious polymersome while allowing reactive oxygen species to pass into the pervious polymersome. Method of treating a patient, comprising: administering an effective amount of a therapeutic composition, the therapeutic composition comprising an anti-reactive oxygen species agent disposed within a pervious polymersome, the pervious polymersome encapsulating the anti-reactive oxygen species agent, and the pervious polymersome having therein channels defined by a channel diblock copolymer, the channels being arranged so as to retain at least some of the anti-reactive oxygen species agent within the pervious polymersome while allowing reactive oxygen species to pass into the pervious polymersome.


Find Patent Forward Citations

Loading…